Publication | Closed Access

A Pilot Study of Apatinib as Third-Line Treatment in Patients With Heavily Treated Metastatic Colorectal Cancer

Gastrointestinal OncologyMedicineCancer ManagementPharmacologyColorectal CancerPathologyCancer TreatmentThird-line TreatmentOncologyRadiation OncologyPilot Study